Lymphatic mapping and sentinel lymphadenectomy for breast cancer
A Chung, AE Giuliano - The Breast, 2018 - Elsevier
The surgical management of the axilla in early breast cancer has significantly evolved over
the past several decades. This chapter details the history of sentinel node dissection, as well …
the past several decades. This chapter details the history of sentinel node dissection, as well …
[HTML][HTML] Diagnosis and management of ductal carcinoma in situ (DCIS).
BA Virnig, T Shamliyan, TM Tuttle… - Evidence report …, 2009 - europepmc.org
Diagnosis and management of ductal carcinoma in situ (DCIS). - Abstract - Europe PMC Sign in
| Create an account https://orcid.org Europe PMC Menu About Tools Developers Help Contact …
| Create an account https://orcid.org Europe PMC Menu About Tools Developers Help Contact …
Sentinel lymph node biopsy in patients with ductal carcinoma in situ: systematic review and meta-analysis
Background Axillary lymph node status remains the most powerful prognostic indicator in
invasive breast cancer. Ductal carcinoma in situ (DCIS) is a non-invasive disease and does …
invasive breast cancer. Ductal carcinoma in situ (DCIS) is a non-invasive disease and does …
Preoperative sentinel node identification with ultrasound using microbubbles in patients with breast cancer
AR Sever, P Mills, SE Jones, K Cox… - American Journal of …, 2011 - Am Roentgen Ray Soc
OBJECTIVE. Sentinel lymph node (SLN) biopsy is the standard procedure for axillary
staging in early breast cancer. Lymphatic imaging after peritumoral microbubble injection …
staging in early breast cancer. Lymphatic imaging after peritumoral microbubble injection …
Consenso sobre la biopsia selectiva del ganglio centinela en el cáncer de mama. Revisión 2013 de la Sociedad Española de Senología y Patología Mamaria
L Bernet, A Piñero, S Vidal-Sicart, V Peg… - Revista Española de …, 2014 - Elsevier
La biopsia selectiva del ganglio centinela es una técnica diagnóstica aceptada como el
procedimiento de elección para la estadificación axilar del cáncer de mama. En este …
procedimiento de elección para la estadificación axilar del cáncer de mama. En este …
Preoperative localization of sentinel lymph nodes using intradermal microbubbles and contrast-enhanced ultrasonography in patients with breast cancer
A Sever, S Jones, K Cox, J Weeks… - Journal of British …, 2009 - academic.oup.com
Background Sentinel lymph node (SLN) biopsy is the standard procedure for axillary staging
in early breast cancer. Lymphatic imaging after intraparenchymal microbubble injection has …
in early breast cancer. Lymphatic imaging after intraparenchymal microbubble injection has …
[HTML][HTML] Factors associated with upstaging from ductal carcinoma in situ following core needle biopsy to invasive cancer in subsequent surgical excision
J Kim, W Han, JW Lee, JM You, HC Shin, SK Ahn… - The Breast, 2012 - Elsevier
OBJECTIVES: The present study tried to identify factors predictive of upstaging from
ultrasound-guided core needle biopsy (CNB)-diagnosed ductal carcinoma in situ (DCIS) to …
ultrasound-guided core needle biopsy (CNB)-diagnosed ductal carcinoma in situ (DCIS) to …
Ductal carcinoma in situ with microinvasion: prognostic implications, long-term outcomes, and role of axillary evaluation
PURPOSE: To compare the clinical-pathologic features and long-term outcomes for women
with ductal carcinoma in situ (DCIS) vs. DCIS with microinvasion (DCISM) treated with breast …
with ductal carcinoma in situ (DCIS) vs. DCIS with microinvasion (DCISM) treated with breast …
Predictors of invasion and axillary lymph node metastasis in patients with a core biopsy diagnosis of ductal carcinoma in situ: an analysis of 255 cases
JS Han, KH Molberg, V Sarode - The breast journal, 2011 - Wiley Online Library
The diagnosis of ductal carcinoma in situ (DCIS) using core biopsy does not ensure the
absence of invasion on final excision. We performed a retrospective analysis of 255 patients …
absence of invasion on final excision. We performed a retrospective analysis of 255 patients …
The role of MRI and clinicopathologic features in predicting the invasive component of biopsy-confirmed ductal carcinoma in situ
GY Yoon, WJ Choi, JH Cha, HJ Shin, EY Chae… - BMC Medical …, 2020 - Springer
Background The upgrade rate of biopsy-confirmed ductal carcinoma in situ (DCIS) to
invasive carcinoma is up to 50% on final pathology. We investigated MRI and …
invasive carcinoma is up to 50% on final pathology. We investigated MRI and …